# Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults

> **NCT02810340** · PHASE1 · COMPLETED · sponsor: **PATH** · enrollment: 60 (actual)

## Conditions studied

- Meningococcal Vaccines

## Interventions

- **BIOLOGICAL:** Adjuvanted MCV-5
- **BIOLOGICAL:** Non-Adjuvanted MCV-5
- **BIOLOGICAL:** Menactra®

## Key facts

- **NCT ID:** NCT02810340
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-01
- **Primary completion:** 2017-10-13
- **Final completion:** 2017-10-13
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02810340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02810340, "Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02810340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*